In 2019, federal legislative and regulatory activities continued to shape and advance the practice of pharmacy, with the Trump Administration and Congress focusing heavily on prescription drug prices and implementation of measures to counter the opioid epidemic and provide support for patients with opioid use disorder (OUD). The Administration also continued its oversight and implementation of regulatory programs, such as compounding, supply chain security, biosimilars, value-based delivery and payment under Medicare, and management of hazardous waste pharmaceuticals.
At the completion of this activity, the participant will be able to:
- Describe federal activities to address drug pricing and the potential impact to pharmacy practice.
- Analyze legislation in 2019 impacting pharmacy practice.
- Explain how federal agency actions will affect or are affecting pharmacy practice.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning level: 1
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-112-H03-P/T.
To obtain credit for APhA Pharmacy Law Matters: A year in review legal and regulatory developments affecting pharmacy in 2019, complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted. The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.
Initial release date: January 1, 2020
Expiration date: January 1, 2023
APhA Pharmacy Law Matters: A year in review legal and regulatory developments affecting pharmacy in 2019, is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association.
Michael A. Mone, BSPharm, JD Vice President, Associate General Counsel for Regulatory Affairs Cardinal Health
Geoff Mospan, PharmD Assistant Professor of Pharmacy Wingate University American Society for Pharmacy Law
Ilisa BG Bernstein, PharmD, JD Senior Vice President, Pharmacy Practice & Government Affairs, APhA
Alicia Kerry Mica, Senior Lobbyist, APhA Michael Baxter Director, Regulatory Affairs, APhA Jenna Ventresca, JD Director, Health Policy, APhA
There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.
Computer and internet access are required to complete this activity. To view the Technology System Requirements, please visit our website.